Brief overview
EDDP stands for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and is the most important metabolite (breakdown product) of methadone. It is produced in the body after methadone intake and is mainly detected in urine.
Why is this important?
- Detecting EDDP is more reliable than detecting methadone alone.
- It helps prevent tampering, because methadone can be added directly to urine, whereas EDDP is formed only through metabolism in the body.
EDDP is therefore considered the diagnostic standard in substitution medicine and in drug screening.
Use in substitution therapy
Methadone is used in Switzerland and internationally, among other things, for:
- Opioid substitution (heroin dependence)
- Relapse prevention
- Stabilisation of physical and social situation
- Reducing illicit use and infection risks
EDDP is not used therapeutically, but for treatment monitoring:
- Regular tests indicate whether methadone has been taken.
- Detection of EDDP confirms metabolism in the body.
Why is EDDP tested and not just methadone?
| Parameter | Meaning |
|---|---|
| Methadone in urine | can be added externally (tampering possible) |
| EDDP in urine | is formed exclusively in the body, therefore hard to manipulate |
| EDDP + methadone | helps distinguish real intake vs. added substance |
This makes EDDP a compliance marker:
- Detected = methadone was taken and metabolised
- Not detected = intake uncertain / circumvention or manipulation possible
Detectability
| Test type | Detection window (indicative) |
|---|---|
| Urine | 2–6 days (longer with chronic intake) |
| Saliva | Rarely used; methadone is usually more relevant |
| Blood | Few hours, but rarely needed clinically |
| Hair | Up to 90 days (depending on use pattern) |
Note: In routine settings, urine testing is generally preferred. EDDP is often detected as part of multipanel opioid/opiate screening.
Risks & special features
EDDP itself is not pharmacologically active. It has:
- no sedating or euphoric effect
- no therapeutic function
Its relevance lies exclusively in laboratory diagnostics.
Screening specifics
- very limited room for manipulation
- high diagnostic value in substitution programmes
- enables adherence monitoring without stigmatisation
Typical detection profiles (combinations)
In screening panels, EDDP is often tested together with:
- methadone
- morphine
- oxycodone
- buprenorphine
- benzodiazepines
EDDP is mainly used in substitution therapy to reliably monitor treatment adherence and the course of methadone intake.
In summary
EDDP is the key reliable metabolite for assessing methadone use in substitution settings and screening. It has no effect on its own, but is used solely to objectively prove that methadone has been metabolised in the body.
